317 related articles for article (PubMed ID: 18488412)
1. Nanocarriers as pulmonary drug delivery systems to treat and to diagnose respiratory and non respiratory diseases.
Smola M; Vandamme T; Sokolowski A
Int J Nanomedicine; 2008; 3(1):1-19. PubMed ID: 18488412
[TBL] [Abstract][Full Text] [Related]
2. Nanomedicine for respiratory diseases.
Swai H; Semete B; Kalombo L; Chelule P; Kisich K; Sievers B
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):255-63. PubMed ID: 20049795
[TBL] [Abstract][Full Text] [Related]
3. Nanocarriers as an emerging platform for cancer therapy.
Peer D; Karp JM; Hong S; Farokhzad OC; Margalit R; Langer R
Nat Nanotechnol; 2007 Dec; 2(12):751-60. PubMed ID: 18654426
[TBL] [Abstract][Full Text] [Related]
4. [The position of respiratory medicine in Germany: status quo and future outlook].
Teschler H; Seeger W; Vogelmeier C
Pneumologie; 2010 Mar; 64(3):143-8. PubMed ID: 20200798
[No Abstract] [Full Text] [Related]
5. Nanotechnology: intelligent design to treat complex disease.
Couvreur P; Vauthier C
Pharm Res; 2006 Jul; 23(7):1417-50. PubMed ID: 16779701
[TBL] [Abstract][Full Text] [Related]
6. [Pneumology - modern, with tradition].
Pfeifer M
Pneumologie; 2010 Mar; 64(3):141-2. PubMed ID: 20200797
[No Abstract] [Full Text] [Related]
7. Nanomedicine and therapy of lung diseases.
Garcia Fde M
Einstein (Sao Paulo); 2014; 12(4):531-3. PubMed ID: 25628213
[TBL] [Abstract][Full Text] [Related]
8. [Pneumological intensive care medicine].
Mayer K; Seeger W
Internist (Berl); 2012 May; 53(5):533. PubMed ID: 22527660
[No Abstract] [Full Text] [Related]
9. PEGylated polyester-based nanoncologicals.
Conte C; d'Angelo I; Miro A; Ungaro F; Quaglia F
Curr Top Med Chem; 2014; 14(9):1097-114. PubMed ID: 24678711
[TBL] [Abstract][Full Text] [Related]
10. Application of Chitosan and its Derivatives in Nanocarrier Based Pulmonary Drug Delivery Systems.
Dua K; Bebawy M; Awasthi R; Tekade RK; Tekade M; Gupta G; De Jesus Andreoli Pinto T; Hansbro PM
Pharm Nanotechnol; 2017; 5(4):243-249. PubMed ID: 28786352
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicine: nanocarriers shape up for long life.
Nishiyama N
Nat Nanotechnol; 2007 Apr; 2(4):203-4. PubMed ID: 18654260
[No Abstract] [Full Text] [Related]
12. [Inhalative pharmacotherapy in the future--nanocarriers for pulmonary drug delivery].
Gessler T
Pneumologie; 2009 Dec; 63 Suppl 2():S113-6. PubMed ID: 20013540
[TBL] [Abstract][Full Text] [Related]
13. [Not Available].
Mülleneisen NK
Pneumologie; 2012 Oct; 66(10):619; author reply 619. PubMed ID: 23055375
[No Abstract] [Full Text] [Related]
14. [Rare diseases in pulmonary medicine and its challenges].
Wencker M; Teschler H; Vogelmeier C; Koczulla R
Pneumologie; 2012 Jul; 66(7):437-41. PubMed ID: 22692970
[TBL] [Abstract][Full Text] [Related]
15. Nanomedicine as an innovative therapeutic strategy for pediatric lung diseases.
Tian Y; Chen J; Zahtabi F; Keijzer R; Xing M
Pediatr Pulmonol; 2013 Nov; 48(11):1098-111. PubMed ID: 23997035
[TBL] [Abstract][Full Text] [Related]
16. Selected nanotechnologies and nanostructures for drug delivery, nanomedicine and cure.
Khan AU; Khan M; Cho MH; Khan MM
Bioprocess Biosyst Eng; 2020 Aug; 43(8):1339-1357. PubMed ID: 32193755
[TBL] [Abstract][Full Text] [Related]
17. Nanotechnology platforms and physiological challenges for cancer therapeutics.
Kim KY
Nanomedicine; 2007 Jun; 3(2):103-10. PubMed ID: 17442621
[TBL] [Abstract][Full Text] [Related]
18. Nanocrystal technology, drug delivery and clinical applications.
Junghanns JU; Müller RH
Int J Nanomedicine; 2008; 3(3):295-309. PubMed ID: 18990939
[TBL] [Abstract][Full Text] [Related]
19. [Neonatal pulmonary pathology].
Magny JF; Dehan M
Rev Mal Respir; 1988; 5(3):239-47. PubMed ID: 3041497
[TBL] [Abstract][Full Text] [Related]
20. Advances in Nanocarriers for Anticancer Drugs Delivery.
Ali I; Lone MN; Suhail M; Mukhtar SD; Asnin L
Curr Med Chem; 2016; 23(20):2159-87. PubMed ID: 27048343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
